![]() |
市场调查报告书
商品编码
1933374
全球采血针市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考量因素以及未来预测(2026-2034)Lancet Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受糖尿病盛行率上升和常规诊断检测需求增加的推动,全球采血针市场在2025年保持稳定成长。根据本报告,全球采血针市场预计在2025年达到23.1亿美元,并从2026年的25.4亿美元成长到2034年的57.4亿美元,预测期内复合年增长率(CAGR)为10.72%。北美地区在2025年占市场主导地位,市占率达34.98%,主要得益于先进血糖监测设备的广泛应用和有利的报销政策。
采血针是一种小型、锋利的医疗器械,主要用于采集毛细血管血样,以进行血糖测量、血红蛋白检测和胆固醇监测。这些器械广泛应用于医院、诊断实验室和家庭医疗保健机构。人们对预防针刺伤的意识不断提高,以及安全型采血针的日益普及,都显着推动了市场成长。
市场动态
市场驱动因素
糖尿病和慢性疾病盛行率的上升是全球采血针市场的主要驱动因素。糖尿病患者广泛使用采血针进行日常血糖监测。根据健康指标与评估研究所(IHME,2023年6月)的数据,全球有超过5亿人患有糖尿病。此外,家庭诊断解决方案的日益普及以及对微创采血技术的偏好,也推动了对先进安全型采血针的需求。
市场限制因子
安全采血针的价格敏感性预计将抑制市场成长,尤其是在发展中地区。安全采血针比传统采血针更昂贵,这限制了其在註重成本的医疗保健系统中的普及。根据英国国家医疗服务体系 (NHS) 2020 年 10 月发布的数据,安全采血针每 100 支的成本约为 4.87 至 5.06 美元,而标准采血针每 100 支的成本约为 2.37 至 4.22 美元,这阻碍了先进产品的广泛应用。
市场机会
对家庭医疗监测需求的成长创造了丰厚的成长机会。随着越来越多的患者在家中管理糖尿病等慢性疾病,对易于使用且安全的采血设备的需求也不断增长。 根据发表在 "印度医学科学杂誌" (2023年12月刊)上的一项研究,35%的患者在家使用血糖仪进行自我监测,这支撑了采血针消费量的增长。
采血针市场趋势
技术创新和永续产品设计正成为关键趋势。製造商正在开发采用弹簧装置和人体工学设计的超细规格(21G-30G)采血针,以最大限度地减少疼痛并提高患者舒适度。此外,更严格的安全锐器法规以及对使用减少塑胶和可生物降解材料的环保设计的日益重视,也影响产品开发。
依类型
市场依类型分为标准采血针、安全采血针及特殊采血针。 预计到 2026 年,安全采血针细分市场将以 51.55% 的市场占有率领先,这主要得益于需要频繁检测的糖尿病患者对采血针的接受度不断提高。
依切口类型划分
市场分为针式采血针和刀片式采血针。预计到 2026 年,针式采血针细分市场将以 93.65% 的市场占有率领先,这主要得益于其疼痛减轻、易于使用和卓越的安全性。
依年龄组别划分
预计到 2025 年和 2026 年,成年人群体将分别以 72.8% 和 72.92% 的市场占有率主导市场,这主要得益于糖尿病和胆固醇检测的高普及率。 预计儿科市场将以 10.1% 的复合年增长率成长。
依规格尺寸划分
23G-28G 规格的针头在 2025 年和 2026 年分别占 73.3% 和 73.35% 的市场占有率,这主要得益于其在舒适度和血液流动效率方面的最佳平衡。
依应用程式划分
血糖监测在 2025 年占 56.3% 的市场占有率,这主要得益于全球糖尿病患者人数的不断增长。 预计血红素检测的复合年增长率将达到 10.8%。
依通路划分
零售药局将占市场主导地位,到 2025 年将保持 51.9% 的市场占有率,这主要得益于其便利性和全面的糖尿病护理服务。
北美地区在健保报销政策和先进医疗基础设施的支持下,将引领市场,预计 2025 年市场规模将达到 8.1 亿美元,2026 年将达到 8.8 亿美元。欧洲市场预计 2025 年将达到 7.8 亿美元,而亚太地区则占 6.2 亿美元。 预计到 2025 年,拉丁美洲和中东及非洲地区的市场规模将分别达到 7,000 万美元和 2,000 万美元。
The global lancet market recorded steady growth in 2025, supported by the rising prevalence of diabetes and increasing demand for routine diagnostic testing. According to the report, the global lancet market size was valued at USD 2.31 billion in 2025 and is projected to grow from USD 2.54 billion in 2026 to USD 5.74 billion by 2034, exhibiting a CAGR of 10.72% during the forecast period. North America dominated the market with a 34.98% share in 2025, driven by strong adoption of advanced blood glucose monitoring devices and favorable reimbursement policies.
Lancets are small, sharp medical devices used for capillary blood sampling, primarily for blood glucose testing, hemoglobin testing, and cholesterol monitoring. These devices are widely used in hospitals, diagnostic laboratories, and home-care settings. Growing awareness regarding needle-stick injury prevention and the rising adoption of safety-engineered lancets are significantly contributing to market expansion.
Market Dynamics
Market Drivers
The rising prevalence of diabetes and chronic diseases is a key driver of the global lancet market. Lancets are extensively used by diabetic patients for daily blood glucose monitoring. According to the Institute for Health Metrics and Evaluation (June 2023), over half a billion people worldwide are living with diabetes. Additionally, increasing adoption of home-based diagnostic solutions and the preference for minimally invasive blood sampling techniques are driving demand for advanced safety lancets.
Market Restraints
The cost sensitivity of safety lancets is expected to restrain market growth, particularly in developing regions. Safety lancets are more expensive than traditional lancets, limiting their adoption in cost-conscious healthcare systems. NHS data published in October 2020 showed that safety lancets cost approximately USD 4.87-5.06 per 100 units, compared to USD 2.37-4.22 per 100 units for standard lancets, discouraging widespread adoption of advanced products.
Market Opportunities
The increasing need for home healthcare monitoring is creating lucrative growth opportunities. As more patients manage chronic conditions such as diabetes at home, demand for easy-to-use and safe blood sampling devices is rising. A study published in the Indian Journal of Medical Specialties (December 2023) indicated that 35% of patients used glucometers for self-monitoring at home, supporting increased lancet consumption.
Lancet Market Trends
Technological advancements and sustainable product designs are emerging as key trends. Manufacturers are developing ultra-fine gauge lancets (21G-30G) with spring-loaded and ergonomic mechanisms to minimize pain and improve patient comfort. Additionally, regulatory emphasis on safety-engineered sharps and growing focus on environmentally friendly designs using reduced plastic and biodegradable materials are influencing product development.
By Type
Based on type, the market is segmented into standard lancets, safety lancets, and specialty lancets. The safety lancets segment is projected to dominate with a 51.55% share in 2026, driven by increasing adoption among diabetic patients requiring frequent testing.
By Incision Type
The market is categorized into needle and blade lancets. The needle segment is projected to lead with a 93.65% share in 2026, owing to reduced pain, ease of use, and superior safety features.
By Age Group
Adults dominated the market with a 72.8% share in 2025 and are expected to account for 72.92% in 2026, supported by higher testing rates for diabetes and cholesterol. The pediatric segment is projected to grow at a CAGR of 10.1%.
By Gauge Size
The 23G-28G segment dominated with a 73.3% share in 2025 and 73.35% in 2026, due to optimal balance between comfort and blood flow efficiency.
By Application
Blood glucose monitoring dominated the market with a 56.3% share in 2025, supported by the increasing global diabetic population. Hemoglobin testing is expected to grow at a CAGR of 10.8%.
By Distribution Channel
Retail pharmacies dominated the market and are projected to hold a 51.9% share in 2025, driven by accessibility and bundled diabetes care offerings.
North America led the market with USD 0.81 billion in 2025 and USD 0.88 billion in 2026, supported by reimbursement policies and advanced healthcare infrastructure. Europe reached USD 0.78 billion in 2025, while Asia Pacific accounted for USD 0.62 billion. Latin America and the Middle East & Africa recorded USD 0.07 billion and USD 0.02 billion, respectively, in 2025.
Competitive Landscape
The global lancet market is highly fragmented, with key players such as BD, HTL-STREFA, Abbott, Cardinal Health, and Terumo Medical Corporation holding significant market presence. These companies focus on product innovation, capacity expansion, and geographic growth. In January 2025, BD announced investments in U.S. manufacturing facilities to increase production capacity for lancets and other critical medical devices.
Conclusion
The global lancet market was valued at USD 2.31 billion in 2025 and is expected to grow from USD 2.54 billion in 2026 to USD 5.74 billion by 2034, supported by rising diabetes prevalence, growing home-based diagnostics, and increasing adoption of safety lancets. North America maintained market dominance, while Europe and Asia Pacific exhibited strong growth potential. Despite challenges related to cost sensitivity and limited healthcare spending in developing regions, technological advancements, safety-focused regulations, and expanding self-monitoring practices are expected to sustain market growth through 2034.
Segmentation By Type
By Incision Type
By Age Group
By Gauge Size
By Application
By Distribution Channel
By Geography
North America (By Type, Incision Type, Age Group, Gauge Size, Application, Distribution Channel, and Country)